Vaccination rates against COVID-19 in patients with severe mental illness attending community mental health services in rural Greece.
Bipolar disorder
COVID-19
rural areas
schizophrenia
severe mental illness
vaccination
Journal
The International journal of social psychiatry
ISSN: 1741-2854
Titre abrégé: Int J Soc Psychiatry
Pays: England
ID NLM: 0374726
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pubmed:
8
3
2022
medline:
18
2
2023
entrez:
7
3
2022
Statut:
ppublish
Résumé
Patients with severe mental illness (SMI) may be at increased risk for COVID-19-related severe morbidity and mortality. There is limited research on the vaccination rates against COVID-19 in patients with SMI. The objective of the present study is to explore vaccination rates and co-relations in patients with SMI, attending community mental health services, namely the Mobile Mental Health Units (MMHUs) in rural Greece. All treatment engaged patients with SMI (schizophrenia-spectrum or bipolar disorder) with two MMHUs (MMHU of Kefalonia, Zakynthos and Ithaca, [MMHU KZI] and MMHU of the prefectures of Ioannina and Thesprotia [MMHU I-T]) in rural Greece were enrolled prospectively over a six-month period. The MMHU I-T had adopted a more proactive approach to patients' vaccination, by informing patients and caregivers for its benefits. Data were analyzed for 197 patients with SMI. The overall vaccination rate was 68.5% and did not differ from the respective rates in the general population. There were no differences in vaccination rates among patients attending the two MMHUs, nor among patients with different diagnoses (schizophrenia spectrum disorders or bipolar disorder). Vaccination was not associated with gender, educational level, history of alcohol and substance abuse, illness duration, or number of previous hospitalizations, whereas the effect size of age was moderate. In more than half non-vaccinated patients the refusal to get vaccinated was associated with fears and concerns as well as false beliefs that are encountered in the general population. In the present sample of treatment-engaged rural patients vaccination rates against COVID-19 appear to be satisfactory. There were no differences in vaccination rates with regard to the interventions that were applied to enhance vaccination. It seems that other forms of intervention should be applied to reluctant patients to modify their attitudes toward vaccination.
Sections du résumé
BACKGROUND
Patients with severe mental illness (SMI) may be at increased risk for COVID-19-related severe morbidity and mortality. There is limited research on the vaccination rates against COVID-19 in patients with SMI.
AIMS
The objective of the present study is to explore vaccination rates and co-relations in patients with SMI, attending community mental health services, namely the Mobile Mental Health Units (MMHUs) in rural Greece.
METHOD
All treatment engaged patients with SMI (schizophrenia-spectrum or bipolar disorder) with two MMHUs (MMHU of Kefalonia, Zakynthos and Ithaca, [MMHU KZI] and MMHU of the prefectures of Ioannina and Thesprotia [MMHU I-T]) in rural Greece were enrolled prospectively over a six-month period. The MMHU I-T had adopted a more proactive approach to patients' vaccination, by informing patients and caregivers for its benefits.
RESULTS
Data were analyzed for 197 patients with SMI. The overall vaccination rate was 68.5% and did not differ from the respective rates in the general population. There were no differences in vaccination rates among patients attending the two MMHUs, nor among patients with different diagnoses (schizophrenia spectrum disorders or bipolar disorder). Vaccination was not associated with gender, educational level, history of alcohol and substance abuse, illness duration, or number of previous hospitalizations, whereas the effect size of age was moderate. In more than half non-vaccinated patients the refusal to get vaccinated was associated with fears and concerns as well as false beliefs that are encountered in the general population.
CONCLUSION
In the present sample of treatment-engaged rural patients vaccination rates against COVID-19 appear to be satisfactory. There were no differences in vaccination rates with regard to the interventions that were applied to enhance vaccination. It seems that other forms of intervention should be applied to reluctant patients to modify their attitudes toward vaccination.
Identifiants
pubmed: 35253527
doi: 10.1177/00207640221081801
pmc: PMC9936167
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
208-215Références
Psychiatry Res. 2021 May;299:113856
pubmed: 33740483
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Schizophr Res. 2021 May;231:49-50
pubmed: 33752107
J Clin Transl Sci. 2020 May 04;4(5):463-467
pubmed: 33244437
Int J Soc Psychiatry. 2022 Mar;68(2):324-333
pubmed: 33472480
Lancet Psychiatry. 2021 Oct;8(10):860-861
pubmed: 34416185
Mol Psychiatry. 2022 Feb;27(2):1248-1255
pubmed: 34873324
World Psychiatry. 2021 Feb;20(1):54-55
pubmed: 33131217
Psychiatriki. 2017 Jan-Mar;28(1):37-45
pubmed: 28541237
Psychiatry Res. 2022 Jan;307:114329
pubmed: 34910966
Int J Environ Res Public Health. 2021 Nov 24;18(23):
pubmed: 34886077
Int J Soc Psychiatry. 2021 Dec;67(8):1046-1057
pubmed: 34024174
Front Psychiatry. 2021 Dec 16;12:805528
pubmed: 34975599
Eur Psychiatry. 2011 Oct;26(7):425-7
pubmed: 20932722
Schizophr Bull. 2021 Aug 21;47(5):1211-1217
pubmed: 33604657
Schizophr Res Treatment. 2013;2013:613956
pubmed: 24222849
J Egypt Public Health Assoc. 2022 Jan 21;97:5
pubmed: 35079435
J Nerv Ment Dis. 2019 Dec;207(12):1012-1018
pubmed: 31703035
JAMA Netw Open. 2021 Nov 1;4(11):e2134969
pubmed: 34812848
Epidemiol Psychiatr Sci. 2021 Oct 14;30:e68
pubmed: 34645538
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
JAMA Psychiatry. 2021 Apr 1;78(4):380-386
pubmed: 33502436
Ann Gen Psychiatry. 2013 Apr 09;12(1):10
pubmed: 23570333
J Neurosci Rural Pract. 2017 Oct-Dec;8(4):556-561
pubmed: 29204014
Acta Neuropsychiatr. 2021 Oct;33(5):273-276
pubmed: 33998428
Lancet Psychiatry. 2021 Oct;8(10):901-908
pubmed: 34364406
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
BJPsych Open. 2021 Jun 01;7(4):e108
pubmed: 34059167
Schizophr Res. 2020 Aug;222:3-5
pubmed: 32473931
Psychiatriki. 2021 Sep 20;32(3):219-223
pubmed: 34390554
Int J Soc Psychiatry. 2020 Mar;66(2):111-117
pubmed: 31692402